Latest Search
Quote
| Back Zoom + Zoom - | ||||
|
TRANSTHERA-B Once Leaps 64% in Early Trading, Soaring 50x in Less Than 3 Mths Since Debut, Surpassing HANSOH PHARMA in Mkt Cap
Recommend 13 Positive 19 Negative 14 |
||||
|
||||
|
TRANSTHERA-B (02617.HK), a semi-IPO that has been on a sharp uptrend in recent days, opened 15% higher this morning (16th) and once surged by 63.7% in early trading to a new high of HKD679.5, which, compared to its listing price of HKD13.15 on June 23, 2025, marked a spike of nearly 50.7 times in less than three months. It last traded at HKD625, up 50.6%, with a volume of 935,900 shares, involving HKD501 million. TRANSTHERA-B was included in the list of securities eligible for Southbound Stock Connect last Monday (8th). It was listed on June 23 at HKD13.15, raising a net amount of HKD161 million. Its latest market cap of over HKD256.7 billion was higher than blue chip stock HANSOH PHARMA (03692.HK)'s market cap of around HKD218.2 billion, and reached about 46% of HENGRUI PHARMA (01276.HK)'s market cap of around HKD554.7 billion. AAStocks Financial News |
||||
Copied to Clipboard
 |
||||
